156 related articles for article (PubMed ID: 34021478)
1. Mannose-conjugated chitosan nanoparticles for delivery of Rifampicin to Osteoarticular tuberculosis.
Prabhu P; Fernandes T; Chaubey P; Kaur P; Narayanan S; Vk R; Sawarkar SP
Drug Deliv Transl Res; 2021 Aug; 11(4):1509-1519. PubMed ID: 34021478
[TBL] [Abstract][Full Text] [Related]
2. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
Chaubey P; Mishra B
Carbohydr Polym; 2014 Jan; 101():1101-8. PubMed ID: 24299880
[TBL] [Abstract][Full Text] [Related]
3. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency.
Pi J; Shen L; Shen H; Yang E; Wang W; Wang R; Huang D; Lee BS; Hu C; Chen C; Jin H; Cai J; Zeng G; Chen ZW
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109777. PubMed ID: 31349400
[TBL] [Abstract][Full Text] [Related]
4. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
Rawal T; Parmar R; Tyagi RK; Butani S
Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
[TBL] [Abstract][Full Text] [Related]
6. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
Kushwaha K; Dwivedi H
Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624
[TBL] [Abstract][Full Text] [Related]
7. Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.
Zu Y; Zhao Q; Zhao X; Zu S; Meng L
Int J Nanomedicine; 2011; 6():3429-41. PubMed ID: 22267927
[TBL] [Abstract][Full Text] [Related]
8. Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages.
Vieira ACC; Chaves LL; Pinheiro M; Lima SAC; Ferreira D; Sarmento B; Reis S
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):653-663. PubMed ID: 29433346
[TBL] [Abstract][Full Text] [Related]
9. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
Hard SAAA; Shivakumar HN; Redhwan MAM
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
[TBL] [Abstract][Full Text] [Related]
10. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
11. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
12. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
13. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
14. Promising Chitosan-Coated Alginate-Tween 80 Nanoparticles as Rifampicin Coadministered Ascorbic Acid Delivery Carrier Against Mycobacterium tuberculosis.
Scolari IR; Páez PL; Sánchez-Borzone ME; Granero GE
AAPS PharmSciTech; 2019 Jan; 20(2):67. PubMed ID: 30627867
[TBL] [Abstract][Full Text] [Related]
15. Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design.
Petkar KC; Chavhan S; Kunda N; Saleem I; Somavarapu S; Taylor KMG; Sawant KK
AAPS PharmSciTech; 2018 May; 19(4):1758-1772. PubMed ID: 29589222
[TBL] [Abstract][Full Text] [Related]
16. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method.
Gupta M; Marwaha RK; Dureja H
Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of chitosan nanoparticles loaded nanofiber hybrid system for vaginal controlled release of benzydamine.
Tuğcu-Demiröz F; Saar S; Kara AA; Yıldız A; Tunçel E; Acartürk F
Eur J Pharm Sci; 2021 Jun; 161():105801. PubMed ID: 33691155
[TBL] [Abstract][Full Text] [Related]
18. Statistical optimization of voriconazole nanoparticles loaded carboxymethyl chitosan-poloxamer based in situ gel for ocular delivery: In vitro, ex vivo, and toxicity assessment.
Pardeshi SR; More MP; Patil PB; Mujumdar A; Naik JB
Drug Deliv Transl Res; 2022 Dec; 12(12):3063-3082. PubMed ID: 35525868
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
20. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis.
Vieira ACC; Chaves LL; Pinheiro S; Pinto S; Pinheiro M; Lima SC; Ferreira D; Sarmento B; Reis S
Int J Pharm; 2018 Jan; 536(1):478-485. PubMed ID: 29203137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
